Subaortic Stenosis in Single-Ventricle Physiology

Anatomy and flow concept in TA/d-TGA/VSD and DILV/d-TGA/BVF (VSD)

In tricuspid atresia (TA) or double-inlet left ventricle (DILV) with d-transposition of the great arteries (d-TGA), “subaortic stenosis (SAS)” is rarely a problem of the aortic valve itself. The key issue is that systemic output must traverse a long, geometry-dependent, shared conduit to reach the aorta—and any restriction along that route becomes a functional systemic outflow obstruction. This concept has been recognized for decades and remains central to contemporary staged palliation. [1–3] (PubMed)

1) The essential anatomic layout

“Where is the aorta, and how does systemic flow reach it?”

In these variants, the dominant functional ventricle is the LV, but the aorta typically arises from the rudimentary RV/outlet chamber (via ventriculo-arterial discordance). As a result, systemic flow must pass through a serial pathway:

1. LV → bulboventricular foramen (BVF) / VSD
2. BVF/VSD → rudimentary RV (outlet chamber)
3. Rudimentary RV → RVOT → aorta

Key implication: the “subaortic area” is not a single ring; it is a multi-segment conduit made of the BVF/VSD + outlet chamber + RVOT. Any narrowing anywhere in this series can be hemodynamically decisive. [2,6] (PubMed)

2) What “Subaortic Stenosis” means in this setting

Definition (functional, not valvar)

SAS = any restriction along the LV → BVF/VSD → outlet chamber → RVOT route that limits systemic output, even when the aortic valve is anatomically normal. [2,6] (PubMed)

Two dominant mechanisms (classic teaching)

• Restrictive VSD in TA/d-TGA → the VSD becomes the bottleneck to the outlet chamber. [2,3] (PubMed)
• Restrictive BVF in DILV/d-TGA → a fixed “window” that may not grow in proportion to systemic output demands. [2,7] (PubMed)

3) Why SAS tends to develop or worsen over time

This is often an acquired problem—a mismatch between a fixed or slowly growing foramen and a growing child’s systemic flow requirement. Several factors repeatedly appear across clinical series and reviews:

• Growth-related mismatch: BVF/VSD may not enlarge proportionally as systemic output needs rise. [6,7] (PubMed)
• Pulmonary artery banding (PAB): while it protects the pulmonary vasculature, it may accelerate systemic outflow obstruction in susceptible anatomy. [2,6] (PubMed)
• “Volume unloading” during staging: changes in loading conditions can unmask or aggravate a borderline pathway, particularly as the patient approaches Glenn/Fontan physiology. [6,8,9] (PubMed)

4) Physiologic consequences

Why a “small BVF” becomes a systemic shock problem

When the LV must eject through a bottleneck to reach the aorta:

• Systemic ventricular afterload rises → hypertrophy, impaired relaxation, higher filling pressures. [6,9] (PubMed)
• Output becomes fragile (preload/heart-rate sensitive) → small shifts in sedation, ventilation, rhythm, or volume can precipitate low output. [8,9] (PubMed)
• Systemic malperfusion dominates → diminished pulses, metabolic acidosis, oliguria, end-organ hypoperfusion.

Fontan relevance: systemic outflow obstruction and the resulting ventricular hypertrophy/diastolic dysfunction are repeatedly emphasized as adverse substrates for Fontan physiology—so this cannot be treated as a “minor gradient.” [6,8] (PubMed)

5) Clinical assessment

Echo-first: define the conduit, then interpret the physiology

A. Map the whole pathway (not just a Doppler number)

• BVF/VSD: 2D dimensions, color acceleration, aliasing, effective “window” geometry.
• Outlet chamber + RVOT: caliber, tortuosity, sites of serial narrowing.
• Aortic arch: coarctation/arch hypoplasia can compound systemic obstruction and must be interrogated. [5] (PubMed)

B. Add ventricular response

• LV hypertrophy and diastolic parameters
• AV valve regurgitation
• Systemic perfusion markers (lactate, urine output, pulse pressure)

C. “Size matters”—and it can help anticipate intervention

Echocardiographic studies support that smaller BVF size is associated with a higher likelihood of early intervention in single-ventricle variants, reinforcing the concept that anatomic substrate predicts physiologic failure rather than the other way around. [10] (PubMed)

6) Strategy principle

“Relieve systemic outflow—and keep it adequate through the entire Fontan pathway.”

The operative goal is not simply “make the BVF bigger.” It is to create a durable systemic outlet that will remain sufficient across staged palliation, when low output is poorly tolerated and the margin for diastolic dysfunction is narrow. [8,9] (PubMed)

Conceptual options (tailored to anatomy and stage)

1. Bypass the vulnerable conduit
• Systemic outflow reconstruction strategies (e.g., Damus-Kaye-Stansel–type solutions) to avoid reliance on a restrictive BVF/VSD as the sole systemic egress. Mid-term results and technical refinements are well described, including settings with associated arch obstruction. [5,7–9] (PubMed)
2. Enlarge the BVF/VSD (selected anatomy)
• Feasible in some morphologies, but must respect conduction tissue, AV valve apparatus, and patch geometry; historical experience highlights both the potential benefit and the procedural hazards when done late or in severe obstruction. [3,9] (PubMed)
3. Timing within staged palliation
• Multiple series emphasize that waiting for severe, established gradients is dangerous; some centers intentionally time systemic outlet interventions with stage transitions (e.g., at Glenn), while others favor earlier strategies based on anatomy and risk trajectory. [6,7,9] (PubMed)

7) Practical take-home mental model

In TA/d-TGA and DILV/d-TGA, the BVF/VSD + outlet chamber + RVOT is the single conduit to the aorta.

Therefore, SAS is a “conduit problem,” not a valve problem—and the clinical priority is to identify, prevent, and definitively address restriction early enough to protect ventricular function for Glenn/Fontan physiology. [6,8,9] (PubMed)

References

[1] Chen SC, Pennington DG, Nouri S, Sivakoff M, Fagan LF. Management of infants with univentricular heart. Am Heart J. 1984;107(6):1252-1256.

[2] Jonas RA, Castaneda AR, Lang P. Single ventricle (single- or double-inlet) complicated by subaortic stenosis: surgical options in infancy. Ann Thorac Surg. 1985;39(4):361-366.

[3] Rothman A, Lang P, Lock JE, Jonas RA, Mayer JE, Castaneda AR. Surgical management of subaortic obstruction in single left ventricle and tricuspid atresia. J Am Coll Cardiol. 1987;10(2):421-426.

[4] Jensen RA Jr, Williams RG, Laks H, Drinkwater D, Kaplan S. Usefulness of banding of the pulmonary trunk with single ventricle physiology at risk for subaortic obstruction. Am J Cardiol. 1996;77(12):1089-1093.

[5] McElhinney DB, Reddy VM, Silverman NH, Hanley FL. Modified Damus-Kaye-Stansel procedure for single ventricle, subaortic stenosis, and arch obstruction in neonates and infants: midterm results and techniques for avoiding circulatory arrest. J Thorac Cardiovasc Surg. 1997;114(5):718-725; discussion 725-726.

[6] Freedom RM. Subaortic obstruction and the Fontan operation. Ann Thorac Surg. 1998;66(2):649-652.

[7] Clarke AJB, Kasahara S, Andrews DR, Cooper SG, Nicholson IA, Chard RB, Nunn GR, Winlaw DS. Mid-term results for double inlet left ventricle and similar morphologies: timing of Damus-Kaye-Stansel. Ann Thorac Surg. 2004;78(2):650-657; discussion 657.

[8] Fraser CD Jr. Management of systemic outlet obstruction in patients undergoing single ventricle palliation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009:70-75.

[9] Alsoufi B. Management of the single ventricle and potentially obstructive systemic ventricular outflow tract. J Saudi Heart Assoc. 2013;25(3):191-202.

[10] Skaff AM, Parra DA, Soslow JH, Shuplock JM. Association of Bulboventricular Foramen Size and Need for Early Intervention in Infants with Tricuspid Atresia or Double-Inlet Left Ventricle with Normally Related Great Arteries. J Am Soc Echocardiogr. 2023;36(3):327-332.